CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 74 filers reported holding CEMPRA INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $15,376,000 | -33.9% | 4,731 | -6.4% | 0.00% | – |
| Q2 2017 | $23,253,000 | +806.5% | 5,055 | +639.0% | 0.00% | – |
| Q1 2017 | $2,565,000 | -71.6% | 684 | -78.8% | 0.00% | – |
| Q4 2016 | $9,036,000 | -89.9% | 3,227 | -12.8% | 0.00% | – |
| Q3 2016 | $89,516,000 | +237.2% | 3,699 | +129.8% | 0.00% | – |
| Q2 2016 | $26,549,000 | -85.9% | 1,610 | -73.3% | 0.00% | – |
| Q4 2015 | $187,776,000 | +1.5% | 6,032 | -9.2% | 0.00% | – |
| Q3 2015 | $184,913,000 | +103.3% | 6,642 | +150.9% | 0.00% | – |
| Q2 2015 | $90,951,000 | +437.7% | 2,647 | +436.9% | 0.00% | – |
| Q1 2015 | $16,915,000 | +1.5% | 493 | -67.6% | 0.00% | – |
| Q3 2014 | $16,659,000 | +908.4% | 1,520 | +887.0% | 0.00% | – |
| Q2 2014 | $1,652,000 | +364.0% | 154 | +294.9% | 0.00% | – |
| Q1 2014 | $356,000 | -88.8% | 39 | -84.8% | 0.00% | – |
| Q4 2013 | $3,172,000 | – | 256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
| Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
| Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
| Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
| Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
| BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
| AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
| GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
| HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |